violators of the SEA.{A}'s actions were considered as serious performance deficiency by willfully imparting false statement and concealing information which should have been stated in the documents filed with
the date on which the Board of Directors’ Meeting would resolve to grant approval for the Company to propose the matter to the Shareholders’ Meeting for consideration and approval for the execution of
grant approval for the Company to propose the matter to the Shareholders’ Meeting for consideration and approval for the execution of this transaction, with the transaction size representing 1.858 percent
the date on which the Board of Directors’ Meeting would resolve to grant approval for the Company to propose the matter to the Shareholders’ Meeting for consideration and approval for the execution of
, provided that such facility is subject to ADB’s internal approvals, due diligence, and execution of mutually agreed definitive documentation. Net proceed from IPO In connection with our IPO, we received net
Operating Performance of EP Unit : THB For the nine-month period ended September 30 2016 2017 Revenues 332,608,989.95 386,594,621.67 Total Expenses 115,059,671.29 211,345,978.91 Net Profits (Losses) for year
20220808-advanc-mdna-2q2022-en 2Q22 MD&A Advanced Info Service Plc. 1 Executive Summary Fading Covid-19 concerns drove 2Q22 economic recovery and AIS performance 2Q22 showed a continuous recovery in
% QoQ. FY22 guidance maintained. For 9M22, AIS performance was in-line with the guidance. The revenue expects to grow with the seasonality trend in the fourth quarter. A slight decline in EBITDA (-2.4
% QoQ. FY22 guidance maintained. For 9M22, AIS performance was in-line with the guidance. The revenue expects to grow with the seasonality trend in the fourth quarter. A slight decline in EBITDA (-2.4
from the Department of Legal Execution, the Anti-Money Laundering Office (AMLO), the Department of Special Investigation (DSI), and the Narcotics Control Board (NCB), etc. In the case where no wrongdoing